These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19203830)

  • 1. Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancer.
    Ulybina YM; Kuligina ES; Mitiushkina NV; Rozanov ME; Ivantsov AO; Ponomariova DN; Togo AV; Levchenko EV; Shutkin VA; Brenister SI; Devilee P; Zhivotovsky B; Hirvonen A; Imyanitov EN
    Cancer Lett; 2009 Jun; 278(2):183-191. PubMed ID: 19203830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of a common variant of the CASP8 gene with reduced risk of breast cancer.
    MacPherson G; Healey CS; Teare MD; Balasubramanian SP; Reed MW; Pharoah PD; Ponder BA; Meuth M; Bhattacharyya NP; Cox A
    J Natl Cancer Inst; 2004 Dec; 96(24):1866-9. PubMed ID: 15601643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of coding apoptotic gene polymorphisms in women with extreme phenotypes of breast cancer predisposition and tolerance.
    Ulybina YM; Kuligina ES; Mitiushkina NV; Sherina NY; Baholdin DV; Voskresenskiy DA; Polyakov IS; Togo AV; Semiglazov VF; Imyanitov EN
    Tumori; 2011; 97(2):248-51. PubMed ID: 21617726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of death receptor 4, Caspase 3 and 5 gene polymorphism with increased risk to bladder cancer in North Indians.
    Mittal RD; Srivastava P; Mittal T; Verma A; Jaiswal PK; Singh V; Mandal RK; Mandhani A
    Eur J Surg Oncol; 2011 Aug; 37(8):727-33. PubMed ID: 21700414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in the tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) do not contribute but Death Receptor (DR4) genes may contribute to susceptibility to head and neck cancer in Pakistani population.
    Sarwar R; Mansoor Q; Farooqi AA; Shahzad S; Fayyaz S; Ismail M
    Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):53-6. PubMed ID: 26718429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant.
    Frank B; Hemminki K; Wappenschmidt B; Meindl A; Klaes R; Schmutzler RK; Bugert P; Untch M; Bartram CR; Burwinkel B
    Carcinogenesis; 2006 Mar; 27(3):606-9. PubMed ID: 16251207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Comparison of extremes' approach provides evidence against the modifying role of NAT2 polymorphism in lung cancer susceptibility.
    Belogubova EV; Kuligina ESh; Togo AV; Karpova MB; Ulibina JM; Shutkin VA; Hanson KP; Popowski K; Mosyagin I; Cascorbi I; Hirvonen A; Imyanitov EN
    Cancer Lett; 2005 Apr; 221(2):177-83. PubMed ID: 15808403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for depletion of CASP5 Ala90Thr heterozygous genotype in aged subjects.
    Ulybina YM; Kuligina ESh; Mitiushkina NV; Sherina NY; Yanus GA; Gorodnova TV; Katanugina AS; Koloskov AV; Togo AV; Imyanitov EN
    Exp Gerontol; 2010 Sep; 45(9):726-9. PubMed ID: 20434535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Associations of Crohn's disease with DR4 and DR5 gene polymorphisms].
    Lin X; Jin L; Pan C; Zheng S; Zhang D; Lin X; Ding R; Jiang L; Jiang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Oct; 32(5):715-22. PubMed ID: 26418999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification.
    Shivapurkar N; Reddy J; Matta H; Sathyanarayana UG; Huang CX; Toyooka S; Minna JD; Chaudhary PM; Gazdar AF
    Oncogene; 2002 Dec; 21(55):8510-4. PubMed ID: 12466971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis.
    Sergentanis TN; Economopoulos KP
    Breast Cancer Res Treat; 2010 Feb; 120(1):229-34. PubMed ID: 19629679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk.
    Frank B; Hemminki K; Shanmugam KS; Meindl A; Klaes R; Schmutzler RK; Wappenschmidt B; Untch M; Bugert P; Bartram CR; Burwinkel B
    Carcinogenesis; 2005 Nov; 26(11):1975-7. PubMed ID: 15975957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy.
    Meyer A; Coinac I; Bogdanova N; Dubrowinskaja N; Turmanov N; Haubold S; Schürmann P; Imkamp F; von Klot C; Merseburger AS; Machtens S; Bremer M; Hillemanns P; Kuczyk MA; Karstens JH; Serth J; Dörk T
    Urol Oncol; 2013 Jan; 31(1):74-81. PubMed ID: 21396839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancer.
    Timirci-Kahraman O; Ozkan NE; Turan S; Farooqi AA; Verim L; Ozturk T; Inal-Gultekin G; Isbir T; Ozturk O; Yaylim I
    Genet Test Mol Biomarkers; 2015 Jun; 19(6):309-15. PubMed ID: 25955868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis.
    Goodman JE; Mechanic LE; Luke BT; Ambs S; Chanock S; Harris CC
    Int J Cancer; 2006 Apr; 118(7):1790-7. PubMed ID: 16217767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Death receptor 4 variants and colorectal cancer risk.
    Frank B; Shanmugam KS; Beckmann L; Hemminki K; Brenner H; Hoffmeister M; Chang-Claude J; Burwinkel B
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):2002-5. PubMed ID: 17035413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of CASP 8 polymorphism and cancer susceptibility: a meta-analysis.
    Ji GH; Li M; Cui Y; Wang JF
    Cell Mol Biol (Noisy-le-grand); 2014 Dec; 60(6):20-8. PubMed ID: 25553350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional variants in cell death pathway genes and risk of pancreatic cancer.
    Yang M; Sun T; Wang L; Yu D; Zhang X; Miao X; Liu J; Zhao D; Li H; Tan W; Lin D
    Clin Cancer Res; 2008 May; 14(10):3230-6. PubMed ID: 18483392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single nucleotide polymorphism in the extracellular domain of TRAIL receptor DR4 at nucleotide 626 in gastric cancer patients in Japan.
    Kuraoka K; Matsumura S; Sanada Y; Nakachi K; Imai K; Eguchi H; Matsusaki K; Oue N; Nakayama H; Yasui W
    Oncol Rep; 2005 Aug; 14(2):465-70. PubMed ID: 16012731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. There is no significant association between death receptor 4 (DR4) gene polymorphisms and lung cancer in Turkish population.
    Taştemir-Korkmaz D; Demirhan O; Kuleci S; Hastürk S
    Pathol Oncol Res; 2013 Oct; 19(4):779-84. PubMed ID: 23661154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.